Alterations in neuroblastoma ganglioside synthesis by induction of GD1b synthase by retinoic acid

British Journal of Cancer

Volumn 91, Issue 2, 2004, Pages 389-397

  Hettmer, S ^a,b   McCarter, R ^a,b   Ladisch, S ^a,b   Kaucic, K ^a,b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Gangliosides; GD1b synthase; Neuroblastoma; Retinoic acid

Indexed keywords

BETA 1,3 GALACTOSYLTRANSFERASE; GALACTOSYLTRANSFERASE; GANGLIOSIDE; RETINOIC ACID; TRANSCORTIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPOGENESIS; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 3843114549     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601914     Document Type: Article

References (49)

1. Floutsis G, Ulsh L, Ladisch S (1989) Immunosuppressive activity of human neuroblastoma tumor gangliosides. Int J Cancer 43: 6-9
2. Fukumoto S, Mutoh T, Hasegawa T, Miyazaki H, Okada M, Goto G, Furukawa K, Urano T (2000) GD3 synthase gene expression in PC12 cells results in the continuous activation of TrkA and ERK1/2 and enhanced proliferation. J Biol Chem 275: 5832-5838
3. Hakomori S (1996) Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 56: 5309-5318
4. Hettmer S, Malott C, Woods W, Ladisch S, Kaucic K (2003) Biological stratification of human neuroblastoma by complex 'b' pathway gangliosides. Cancer Res 63: 7270-7276
5. Hirschberg K, Zisling R, van Echten-Deckert G, Futerman AH (1996) Ganglioside synthesis during the development of neuronal polarity. Major changes occur during axonogenesis and axon elongation, but not during dendrite growth or synaptogenesis. J Biol Chem 271: 14876-14882
6. Hynds DL, Summers M, Van Brocklyn J, O'Dorisio MS, Yates AJ (1995) Gangliosides inhibit platelet-derived growth factor-stimulated growth, receptor phosphorylation, and dimerization in neuroblastoma SH-SY5Y cells. J Neurochem 65: 2251-2258
7. Kanda N, Nakai K, Watanabe S (2001) Gangliosides GD1b, GT1b, and GQ1b suppress the growth of human melanoma by inhibiting interleukin-8 production: the inhibition of adenylate cyclase. J Invest Dermatol 117: 284-293
8. Kanda N, Tamaki K (1998) Ganglioside GQ1b enhances Ig production by human PBMCs. J Allergy Clin Immunol 102: 813-820
9. Kanda N, Tamaki K (1999a) Ganglioside GD1b supresses immunoglobulin production by human peripheral blood mononuclear cells. Exp Hematol 27: 1487-1493
10. Kanda N, Tamaki K (1999b) Ganglioside GT1b suppresses immunoglobulin production by human peripheral blood mononuclear cells. Immunology 96: 628-633
11. Kanda N, Watanabe S (2001) Gangliosides GD1b, GT1b, and GQ1b enhance IL-2 and IFN-gamma production and suppress IL-4 and IL-5 production in phytohemagglutinin-stimulated human T cells. J Immunol 166: 72-80
12. Kaucic K, Etue N, LaFleur B, Woods W, Ladisch S (2001) Neuroblastomas of infancy exhibit a characteristic ganglioside pattern. Cancer 91: 785-793
13. Kemp SF, Stoolmiller AC (1976) Studies on the biosynthesis of glycosphingolipids in cultured mouse neuroblastoma cells: characterization and acceptor specificities of N-acetylneuraminyl- and N- acetylgalactosaminyltransferases. J Neurochem 27: 723-732
14. Kohl NE, Kanda N, Schreck RR, Bruns G, Latt SA, Gilbert F, Alt FW (1983) Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell 35: 359-367
15. Kojima N, Kurosawa N, Nishi T, Hanai N, Tsuji S (1994) Induction of cholinergic differentiation with neurite sprouting by de novo biosynthesis and expression of GD3 and b-series gangliosides in Neuro2a cells. J Biol Chem 269: 30451-30456
16. Ladisch S, Gillard B (1985) A solvent partition method for microscale ganglioside purification. Anal Biochem 146: 220-231
17. Ladisch S, Kitada S, Hays EF (1987) Gangliosides shed by tumor cells enhance tumor formation in mice. J Clin Invest 79: 1879-1882
18. Ladisch S, Li R, Olson E (1994) Ceramide structure predicts tumor ganglioside immunosuppressive activity. Proc Natl Acad Sci USA 91: 1974-1978
19. Ledeen RW, Yu RK (1982) Gangliosides: structure, isolation, and analysis. Methods Enzymol 83: 139-191
20. Leskawa KC, Hogan EL (1985) Quantitation of the in vitro neuroblastoma response to exogenous, purified gangliosides. J Neurosci Res 13: 539-550
21. Levine JM, Flynn P (1986) Cell surface changes accompanying the neural differentiation of an embryonal carcinoma cell line. J Neurosci 6: 3374-3384
22. Li R, Ladisch S (1991) Shedding of human neuroblastoma gangliosides. Biochim Biophys Acta 1083: 57-64
23. Li R, Ladisch S (1992) Alteration of neuroblastoma ganglioside metabolism by retinoic acid. J Neurochem 59: 2297-2303
24. Li R, Ladisch S (1997) Inhibition of endogenous ganglioside synthesis does not block neurite formation by retinoic acid-treated neuroblastoma cells. J Biol Chem 272: 1349-1354
25. Liour SS, Kapitonov D, Yu RK (2000) Expression of gangliosides in neuronal development of P19 embryonal carcinoma stem cells. J Neurosci Res 62: 363-373
26. Lovat PE, Lowis SP, Pearson AD, Malcolm AJ, Redfern CP (1994) Concentration-dependent effects of 9-cis retinoic acid on neuroblastoma differentiation and proliferation in vitro. Neurosci Lett 182: 29-32
27. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 341: 1165-1173
28. Melino G, Thiele CJ, Knight RA, Piacentini M (1997) Retinoids and the control of growth/death decisions in human neuroblastoma cell lines. J Neurooncol 31: 65-83
29. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM (1993) Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328: 847-854
30. Osanai T, Watanabe Y, Sanai Y (1997) Glycolipid sialyltransferases are enhanced during neural differentiation of mouse embryonic carcinoma cells, P19. Biochem Biophys Res Commun 241: 327-333
31. Pohlentz G, Kaes C, Sandhoff K (2000) In vitro assays for enzymes of ganglioside synthesis. Methods Enzymol 311: 82-94
32. Rebhan M, Vacun G, Bayreuther K, Rosner H (1994) Altered ganglioside expression by SH-SY5Y cells upon retinoic acid- induced neuronal differentiation. NeuroReport 5: 941-944
33. Rettig WJ, Spengler BA, Chesa PG, Old LJ, Biedler JL (1987) Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res 47: 1383-1389
34. Reynolds CP, Biedler JL, Spengler BA, Reynolds DA, Ross RA, Frenkel EP, Smith RG (1986) Characterization of human neuroblastoma cell lines established before and after therapy. J Natl Cancer Inst 76: 375-387
35. Reynolds CP, Lemons RS (2001) Retinoid therapy of childhood cancer. Hematol Oncol Clin North Am 15: 867-910
36. Rizzo AM, Gornati R, Rossi F, Bernardini G, Berra B (1995) Retinoic acid induces changes in Xenopus embryo glycolipid pattern. Cell Biol Int 19: 895-901
37. Rosner H (1998) Significance of gangliosides in neuronal differentiation of neuroblastoma cells and neurite growth in tissue culture. Ann N Y Acad Sci 845: 200-214
38. Schengrund CL, Repman MA, Shochat SJ (1985) Ganglioside composition of human neuroblastomas. Correlation with prognosis. A Pediatric Oncology Group Study. Cancer 56: 2640-2646
39. Schengrund CL, Shochat SJ (1988) Gangliosides in neuroblastomas. Neurochem Pathol 8: 189-202
40. Sheikh KA, Sun J, Liu Y, Kawai H, Crawford TO, Proia RL, Griffin JW, Schnaar RL (1999) Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci USA 96: 7532-7537
41. Srinivas L, Colburn NH (1982) Ganglioside changes induced by tumor promoters in promotable JB6 mouse epidermal cells: antagonism by an antipromoter. J Natl Cancer Inst 68: 469-473
42. Sung CC, Pearl DK, Coons SW, Scheithauer BW, Johnson PC, Zheng M, Yates AJ (1995) Correlation of ganglioside patterns of primary brain tumors with survival. Cancer 75: 851-859
43. Svennerholm L, Bostrom K, Fredman P, Mansson JE, Rosengren B, Rynmark BM (1989) Human brain gangliosides: developmental changes from early fetal stage to advanced age. Biochim Biophys Acta 1005: 109-117
44. Takamiya K, Yamamoto A, Furukawa K, Yamashiro S, Shin M, Okada M, Fukumoto S, Haraguchi M, Takeda N, Fujimura K, Sakae M, Kishikawa M, Shiku H, Aizawa S (1996) Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc Natl Acad Sci USA 93: 10662-10667
45. Tsuji S, Arita M, Nagai Y (1983) GQ1b, a bioactive ganglioside that exhibits novel nerve growth factor (NGF)-like activities in the two neuroblastoma cell lines. J Biochem (Tokyo) 94: 303-306
46. Valentino L, Moss T, Olson E, Wang HJ, Elashoff R, Ladisch S (1990) Shed tumor gangliosides and progression of human neuroblastoma. Blood 75: 1564-1567
47. van Echten G, Sandhoff K (1993) Ganglioside metabolism. Enzymology, topology, and regulation. J Biol Chem 268: 5341-5344
48. Wu ZL, Schwartz E, Seeger R, Ladisch S (1986) Expression of GD2 ganglioside by untreated primary human neuroblastomas. Cancer Res 46: 440-443
49. Yates AJ, Franklin TK, McKinney P, Collins R, Comas T, Boesel CP, Pearl DK (1999) Gangliosides and neutral glycolipids in ependymal, neuronal and primitive neuroectodermal tumors. J Mol Neurosci 12: 111-121